Latest News
Trilantic Europe, a private equity firm focused on mid-market transactions in Europe, has acquired Oberberg Group, an operator of psychotherapy, psychiatry and psychosomatic acute clinics in Germany, with a focus on treatments for depression and addictions.
The transaction allows Trilantic Europe to invest in a leading and specialised healthcare operator in the German private psychotherapy market based on an attractive portfolio of clinics and a unique therapy concept.
Oberberg Group operates nine clinics at eight locations with approximately 560 beds focused on privately insured patients. The clinics operate under different brands including Oberberg Kliniken, SOMNIA Privatkliniken, Rhein-Jura Klinik and
Victory Park Capital (VPC), an investment firm focused on middle-market debt and equity investments, has appointed Troy Jamison as chief risk officer (CRO) for the firm’s nonbank financial services portfolio.
Jamison is based in Chicago and reports directly to CEO and Co-Founder Richard Levy.
As VPC’s first CRO, Jamison oversees the assessment and management of risk within the firm’s credit and equity portfolios, as well as evaluates and executes investments and assists portfolio companies with strategic initiatives.
“Troy’s notable experience and expertise in all areas of our business will be a true value-add in evaluating risk and advising
Global law firm Ropes & Gray has appointed Keren Rimon as counsel in the firm’s private investment funds practice in Boston.
Rimon joins Ropes & Gray from Harvard Management Company where she most recently held the position of Senior Vice President – Private Funds. In this capacity, Rimon provided comprehensive legal support to HMC’s hedge fund, absolute return and private equity portfolios. This included managing legal processes across a wide range of fund investment matters on behalf of the endowment. Rimon also advised HMC’s portfolio teams on complex investment structures tailored to the endowment, including separately managed accounts, single-member funds
Alter Domus, a provider of fund and corporate services to alternative investment managers, is to acquire Cortland Capital Markets Services (Cortland) in the US. The terms of the transaction have not been disclosed.
Headquartered in Chicago and with offices in New York, London, Los Angeles, Austin, Indianapolis, and China, Cortland is a leading independent investment servicing company providing third – party fund administration and middle and back – office outsourcing to financial institutions, including alternative investment managers, real estate private equity firms and cred it funds. It currently has over USD180 billion of assets under administration. The firm was founded
Offshore law firm Carey Olsen has expanded its finance practice in the Cayman Islands with the appointment of Dylan Wiltermuth who has joined the firm as Counsel.
Wiltermuth (pictured), is an experienced Cayman Islands lawyer who specialises in all aspects of structured finance and securitisation transactions as well as public and private mergers and acquisitions. His recent capital market experience includes a substantial number of CLO closings and advising a number of leading global banks and issuers.
He joins Carey Olsen’s rapidly expanding team in the Cayman Islands, which is widely recognised for advising global financial institutions on innovative
Sixth Element Capital (6EC), a UK based fund manager established to manage investments for the GBP70 million CRT Pioneer Fund, has made a GBP3 million investment in NeoPhore Ltd, a spin out from Cambridge, UK based PhoreMost Ltd.
NeoPhore is focused on the discovery and development of novel small molecule therapies to treat cancer through stimulation of the immune system. The investment will be used to build on the discoveries already made by PhoreMost and its collaborators. NeoPhore’s drug target rationale is highly validated by genetic evidence in cancer patients and cellular models.
NeoPhore aims to exploit novel biological
Exaltare Capital Partners has appointed Benjamin Kahn as a Managing Director. Kahn joins from HIG Growth Partners where he served as a Principal in the Boston office and had worked for nine years.
“We are excited to have a professional with Ben’s background and level of private equity experience join our team. Ben has a proven track record investing in and managing portfolio companies across Exaltare’s four key industry verticals. With the recent closing of our initial institutional private equity fund, Ben will help lead our investment effort as we look to further build the portfolio,” says Omar Simmons, founder
Actic International, a holding company owned by the IK 2007 Fund, is to sell 6,647,078 shares in Actic Group AB (Actic) to nine high quality Swedish investors, including Athanase Industrial Partner (Athanase).
As a result, Athanase, a cornerstone investor in the listing of Actic, will increase its holding in Actic from approximately 7.9 per cent to 15.4 per cent of the total number of shares outstanding. The IK 2007 Fund, meanwhile, advised by IK Investment Partners, will no longer own any shares in Actic.
SEB acted as Sole Bookrunner in the transaction.
Funds managed by Inflexion Private Equity have acquired Atcore Group (Atcore), a leading travel technology company which provides specialist software platforms for the global leisure travel sector.
With clients such as TUI, Thomas Cook and Mark Warner, Atcore comprises of two principal platforms, Atcom and Tigerbay. Atcom designs, builds and maintains reservation software for leading global tour operators. Its proprietary reservation system is highly complex, and supports sophisticated business models which allow clients to manage large volumes of search requests, optimise customer experience and enhance profitability. Tigerbay serves specialist travel companies. It operates a dynamic, flexible, end to end platform
Italmatch Chemicals Group (Italmatch) is to acquire Detrex for USD27 a share in cash following the agreement of a merger deal between the two companies.
Under the terms of the Merger Agreement dated 10 November, 2017, each share of Detrex common stock outstanding immediately prior to the merger will be converted into and exchanged for the right to receive USD27.00 in cash. The merger consideration represents an 8 per cent premium over the closing bid price of Detrex’s common stock as quoted on the website of OTC Markets Group on 9 November, 2017, and a 9 per cent premium over
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
